Susanne A Schneider Selected Research

Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)

1/2021	Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.
10/2019	Iron chelation in pantothenate kinase-associated neurodegeneration: A possible new avenue for slowing down disease progression in neurodegeneration.
12/2016	Iron chelation in the treatment of neurodegenerative diseases.
12/2014	7-Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers.
8/2012	Neurodegeneration with brain iron accumulation.
6/2012	Syndromes of neurodegeneration with brain iron accumulation.
9/2010	Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susanne A Schneider Research Topics

Disease

16	Dystonia (Limb Dystonia) 06/2021 - 04/2008
14	Parkinson Disease (Parkinson's Disease) 03/2020 - 10/2006
11	Parkinsonian Disorders (Parkinsonism) 01/2022 - 01/2009
9	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2021 - 01/2013
7	Neurodegeneration with brain iron accumulation (NBIA) 01/2021 - 11/2010
7	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 01/2021 - 09/2010
7	Tremor (Tremors) 10/2015 - 10/2006
6	Movement Disorders (Movement Disorder) 01/2021 - 07/2010
5	Atrophy 01/2022 - 01/2009
5	Dyskinesias (Dyskinesia) 01/2022 - 06/2008
5	Cognitive Dysfunction 01/2021 - 09/2010
4	Disease Progression 01/2021 - 03/2016
4	Essential Tremor (Essential Tremors) 12/2016 - 09/2006
3	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 03/2022 - 07/2020
3	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 01/2021 - 01/2009
3	Dopa-responsive Dystonia 06/2015 - 06/2009
3	Torticollis (Wryneck) 02/2014 - 12/2012
2	Chorea (Rheumatic Chorea) 01/2021 - 06/2009
2	Seizures (Absence Seizure) 01/2020 - 10/2013
2	Epilepsy (Aura) 01/2020 - 06/2008
2	Hepatolenticular Degeneration (Wilson's Disease) 01/2018 - 11/2010
2	Nervous System Diseases (Neurological Disorders) 12/2016 - 01/2013
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 07/2016 - 04/2008
2	Hypokinesia (Bradykinesia) 06/2014 - 04/2010
2	Neuroferritinopathy 06/2012 - 11/2010
2	Dystonia musculorum deformans type 1 02/2012 - 10/2010
1	Gaucher Disease (Gaucher's Disease) 06/2021
1	Splenomegaly 06/2021
1	Dementia (Dementias) 06/2021
1	Motor Neuron Disease (Primary Lateral Sclerosis) 06/2021
1	Speech Disorders (Cluttering) 01/2021
1	Ganglion Cysts (Ganglion) 07/2020
1	Retinal Degeneration 07/2020
1	Cataract (Cataracts) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 12/2016
1	Multiple Sclerosis 12/2016
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 09/2016
1	Urinary Retention 09/2016
1	Frontotemporal Dementia (Semantic Dementia) 07/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2016
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 03/2016
1	Task-Specific Focal Dystonia 01/2016
1	Drug-Related Side Effects and Adverse Reactions 03/2015
1	Inflammation (Inflammations) 01/2015
1	Glioma (Gliomas) 10/2013

Drug/Important Bio-Agent (IBA)

20	IronIBA 01/2022 - 01/2009
13	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2009
4	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2011 - 11/2007
3	Pharmaceutical PreparationsIBA 01/2017 - 10/2013
3	alpha-SynucleinIBA 01/2017 - 07/2015
3	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 03/2010
2	Glucosylceramidase (Glucocerebrosidase)IBA 06/2021 - 01/2020
2	LipidsIBA 01/2021 - 01/2013
2	Phospholipases A2 (Phospholipase A2)IBA 01/2021 - 04/2012
2	CeramidesIBA 01/2021 - 04/2013
2	Familial apoceruloplasmin deficiencyIBA 12/2016 - 06/2012
2	Type A Botulinum Toxins (Botox)FDA Link 09/2016 - 10/2006
2	SynucleinsIBA 01/2015 - 04/2013
2	Ion Channels (Ion Channel)IBA 02/2014 - 12/2012
2	Botulinum Toxins (Botulinum Toxin)IBA 01/2014 - 10/2006
2	Leucine (L-Leucine)FDA Link 10/2013 - 06/2011
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 08/2012 - 06/2012
2	pantothenate kinaseIBA 04/2012 - 11/2010
1	acetylleucineIBA 03/2022
1	Filipin (Filipin III)IBA 06/2021
1	Desipramine (Pertofrane)FDA LinkGeneric 01/2021
1	DeferiproneIBA 01/2021
1	Retinaldehyde (Retinal)IBA 07/2020
1	Ambroxol (Mucosolvan)IBA 01/2020
1	Citric Acid (Citrate)FDA LinkGeneric 01/2020
1	citrate-binding transport proteinIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2016
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 07/2016
1	Crystallins (Crystallin)IBA 04/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2016
1	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 06/2015
1	MetalloproteinsIBA 01/2015
1	Ceruloplasmin (Ferroxidase)IBA 01/2015
1	AnoctaminsIBA 06/2014
1	SodiumIBA 02/2014
1	Propranolol (Inderal)FDA LinkGeneric 01/2014
1	Clonazepam (Rivotril)FDA LinkGeneric 01/2014
1	Primidone (Sertan)FDA LinkGeneric 01/2014
1	Antidepressive Agents (Antidepressants)IBA 01/2014
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2014
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2014
1	Prednisolone (Predate)FDA LinkGeneric 10/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2013
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 10/2013

Therapy/Procedure

8	Therapeutics 06/2021 - 01/2008
4	Deep Brain Stimulation 03/2015 - 07/2010
2	Precision Medicine 03/2020 - 01/2020
1	Lenses 01/2017
1	Phacoemulsification 01/2017
1	Chelation Therapy (Therapy, Chelation) 12/2016
1	Aftercare (After-Treatment) 09/2016
1	Electrodes (Electrode) 10/2015
1	Immunotherapy 10/2013